Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study

被引:0
|
作者
M. Toeller
A. Buyken
G. Heitkamp
S. Brämswig
J. Mann
R. Milne
F. A. Gries
H. Keen
机构
[1] Diabetes Research Institute at the Heinrich-Heine-University,
[2] Clinical Department,undefined
[3] Düsseldorf,undefined
[4] Germany,undefined
[5] University of Otago,undefined
[6] Department of Nutrition,undefined
[7] Dunedin,undefined
[8] New Zealand,undefined
[9] Unit for Metabolic Medicine,undefined
[10] United Medical and Dental Schools,undefined
[11] Guy's Hospital Campus,undefined
[12] London,undefined
[13] UK,undefined
来源
Diabetologia | 1997年 / 40卷
关键词
Keywords Insulin-dependent diabetes mellitus; protein intake; urinary albumin excretion rate; diabetic nephropathy; diet recommendations; Europe.;
D O I
暂无
中图分类号
学科分类号
摘要
For people with insulin-dependent diabetes mellitus (IDDM) renal disease represents a life-threatening and costly complication. The EURODIAB IDDM Complications Study, a cross-sectional, clinic-based study, was designed to determine the prevalence of renal complications and putative risk factors in stratified samples of European individuals with IDDM. The present study examined the relationship between dietary protein intake and urinary albumin excretion rate (AER). Food intake was assessed centrally by a standardized 3-day dietary record. Urinary AER was determined in a central laboratory from a timed 24-h urine collection. Complete data were available from 2696 persons with IDDM from 30 centres in 16 European countries. In individuals who reported protein consumption less than 20 % of total food energy intake, mean AER was below 20 μg/min. In those in whom protein intake constituted more than 20 %, mean AER increased, a trend particularly pronounced in individuals with hypertension and/or poor metabolic control. Trends reached statistical significance for intakes of total protein (% of energy, p = 0.01) and animal protein (% of energy, p = 0.02), while no association was seen for vegetable protein (p = 0.83). These findings support the current recommendation for people with diabetes not to exceed a protein intake of 20 % of total energy. Monitoring and adjustment of dietary protein appears particularly desirable for individuals with AER exceeding 20 μg/min (approximately 30 mg/24 h), especially when arterial pressure is raised and/or diabetic control is poor. [Diabetologia (1997) 40: 1219–1226]
引用
收藏
页码:1219 / 1226
页数:7
相关论文
共 50 条
  • [21] THE RELATIONSHIP BETWEEN PREGNANCY AND LONG-TERM MATERNAL COMPLICATIONS IN THE EURODIAB IDDM COMPLICATIONS STUDY
    CHATURVEDI, N
    STEPHENSON, JM
    FULLER, JH
    KARAMANOS, B
    TOUNTAS, C
    KOFINIS, A
    PETROU, K
    KATSILAMBROS, N
    CIGNARELLI, M
    GIORGINO, R
    DECICCO, ML
    RAMUNNI, I
    DEGECO, ML
    IONESCUTIRGOVISTE, C
    IOSIF, CM
    PITEI, D
    BULIGESCU, S
    TAMAS, G
    KERENYI, Z
    AHMED, AM
    TOTH, J
    KEMPLER, P
    MUNTONI, S
    SONGINI, M
    STABILINI, M
    FOSSARELLO, M
    PINTUS, S
    MUNTONI, S
    SANMICHELE, O
    FERRISS, JB
    CRONIN, CC
    WHYTE, AE
    CLEARY, PE
    TOELLER, M
    KLISCHAN, A
    FORST, T
    GRIES, FA
    ROTTIERS, R
    PRIEM, H
    EBELING, P
    SINISALO, M
    KOIVISTO, VA
    IDZIORWALUS, B
    SOLNICA, B
    SZOPINSKACIBA, L
    SOLNICA, K
    KRANS, HMJ
    LEMKES, HHPJ
    JANSEN, JJ
    BRACHTER, J
    DIABETIC MEDICINE, 1995, 12 (06) : 494 - 499
  • [22] Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study
    Stephenson, JM
    Kempler, P
    Perin, PC
    Fuller, JH
    DIABETOLOGIA, 1996, 39 (11) : 1372 - 1376
  • [23] ADHESION MOLECULES ARE NOT INCREASED IN IDDM WITH ELEVATED URINARY ALBUMIN EXCRETION RATE
    FRANK, M
    KOPP, HP
    KRUGLUGER, W
    HOPMEIER, P
    SCHERNTHANER, G
    DIABETOLOGIA, 1995, 38 : A211 - A211
  • [24] SYSTOLIC HYPERTENSION IN IDDM PATIENTS WITH HYPERFILTRATION AND NORMAL ALBUMIN EXCRETION RATES
    AZEVEDO, MJ
    GROSS, JL
    DIABETES CARE, 1990, 13 (04) : 452 - 453
  • [25] A comparison of renal disease across two continents - The Epidemiology of Diabetes Complications Study and the EURODIAB IDDM Complications Study
    Lloyd, CE
    Stephenson, J
    Fuller, JH
    Orchard, TJ
    DIABETES CARE, 1996, 19 (03) : 219 - 225
  • [26] Circulating and urinary transforming growth factor β1, Amadori albumin, and complications of type 1 diabetes -: The EURODIAB Prospective Complications Study
    Chaturvedi, N
    Schalkwijk, CG
    Abrahamian, H
    Fuller, JH
    Stehouwer, CDA
    DIABETES CARE, 2002, 25 (12) : 2320 - 2327
  • [27] Blood pressure response to standing in the diagnosis of autonomic neuropathy:: The EURODIAB IDDM Complications Study
    Kempler, P
    Tesfaye, S
    Stevens, LK
    Kerényi, Z
    Tamás, G
    Ward, JD
    Fuller, JH
    DIABETOLOGIA, 1999, 42 : A297 - A297
  • [28] METHODOLOGY FOR RETINAL PHOTOGRAPHY AND ASSESSMENT OF DIABETIC-RETINOPATHY - THE EURODIAB IDDM COMPLICATIONS STUDY
    ALDINGTON, SJ
    KOHNER, EM
    MEUER, S
    KLEIN, R
    SJOLIE, AK
    DIABETOLOGIA, 1995, 38 (04) : 437 - 444
  • [29] Retinopathy and vision loss in insulin dependent diabetes in Europe - The EURODIAB IDDM complications study
    Sjolie, AK
    Stephenson, J
    Aldington, S
    Kohner, E
    Janka, H
    Stevens, L
    Fuller, J
    OPHTHALMOLOGY, 1997, 104 (02) : 252 - 260
  • [30] Autonomic neuropathy is associated with increased cardiovascular risk factors:: the EURODIAB IDDM Complications Study
    Kempler, P
    Tesfaye, S
    Chaturvedi, N
    Stevens, LK
    Webb, DJ
    Eaton, S
    Kerényi, Z
    Tamás, G
    Ward, JD
    Fuller, JH
    DIABETIC MEDICINE, 2002, 19 (11) : 900 - 909